The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Gazyva (obinutuzumab)
Australian Public Assessment Report
Device/Product Name
Gazyva
Active ingredients
Obinutuzumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-03031-1-6
Submission Type
Extension of indication
Decision
Approved